Psychoactive Prescription Practices for Serious Mental and Neurological Illness in Ghana: Data from the Mental Health and Poverty Project (MHaPP)

International Journal of Mental Health

Volumn 45, Issue 4, 2016, Pages 223-235

  Canavan, Maureen ^a   Sipsma, Heather ^a   Jack, Helen ^b   Ohene, Sammy ^c   Rohrbaugh, Robert ^d   Bradley, Elizabeth ^a   Ofori Atta, Angela ^c  

^a YALE UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF GHANA   (Ghana)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

LMIC; mental and neurological disorders; psychoactive medication

Indexed keywords

EID: 84984685543     PISSN: 00207411     EISSN: 15579328     Source Type: Journal    
DOI: 10.1080/00207411.2016.1215217     Document Type: Article

References (27)

1. H.A.Whiteford, ; L.Degenhardt, ; J.Rehm, ; A.J.Baxter, ; A.J.Ferrari, ; (2013) Global burden of disease attributable to mental and substance use disorders:findings from the Global Burden of Disease Study 2010. The Lancet, 382, 1575–1586.
2. M.E.Canavan, ; H.L.Sipsma, ; A.Adhvaryu, ; A.Ofori-Atta, ; H.Jack, ; (2013) Psychological distress in Ghana:Associations with employment and lost productivity. International Journal of Mental Health Systems, 7, 9.
3. D.Bloom, ; E.Cafiero, ; E.Jané-Llopis, ; S.Abrahams-Gessel, ; L.Bloom, ; (2011). The global economic burden of noncommunicable diseases. Geneva, Switzerland:World Economic Forum.
4. C.Lund, ; M.DeSilva, ; S.Plagerson, ; S.Cooper, ; D.Chisholm, ; J.Das, ; M.Knapp, & V.Patel, (2011) Poverty and mental disorders:Breaking the cycle in low-income and middle-income countries. The Lancet, 378, 1502–1514.
5. World Health Organization. (2007). Ghana country summary. Mental Health Improvement for Nations’ Development (MIND). Geneva, Switzerland:World Health Organization, Department of Mental Health and Substance Abuse. Available at http://www.who.int/mental_health/policy/country/GhanaCoutrySummary_Oct2007.pdf?ua=1
6. World Health Organization. (2011) Mental health atlas 2011. Geneva, Switzerland:World Health Organization.
7. U.M.Read, & V.C.K.Doku, (2012) Mental health research in Ghana:A literature review. Ghana Medical Journal, 46, 29–38.
8. D.Chisholm, & S.Saxena, (2012) Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia:Mathematical modelling study. BMJ 344.
9. A.B.Adeponle, ; A.O.Obembe, ; F.Nnaji, ; S.O.Adeyemi, ; & G.Suleiman, (2008) Psychotropic drug prescription at two regional psychiatric hospitals in Northern Nigeria. West African Journal of Medicine, 27, 106–110.
10. A.B.Adeponle, ; A.O.Obembe, ; S.O.Adeyemi, & G.Suleiman, (2007) Polypharmacy in psychiatric outpatient practice in northern Nigeria. African Journal of Psychiatry, 10, 215–218.
11. I.O.Agbonile, & O.Famuyiwa, (2009) Psychotropic drug prescribing in a Nigerian psychiatric hospital. International Psychiatry, 6, 96–97.
12. O.Famuyiwa, (1996) Intra-city differences in psychotropic drug use:A Nigerian scene. The Journal of the Royal Society for the Promotion of Health, 116, 299–303.
13. O.Famuyiwa, (1983) Psychotropic drug prescription in Nigeria. Acta Psychiatrica Scandinavica, 68, 73–81.
14. A.Sanati, (2009) Investigating the quality of psychotropic drug prescriptions at Accra Psychiatric Hospital. International Psychiatry, 6, 69–70.
15. N.Sandson, ; K.Cozza, ; S.Armstrong, ; G.Eckermann, ; B.Fischer, ; (2007) Med-psych drug-drug interactions update:Clozapine case series. Psychosomatics, 48, 170–175.
16. W.G.Honer, ; A.E.Thornton, ; E.Y.H.Chen, ; R.C.K.Chan, ; J.O.Y.Wong, ; (2006) Clozapine alone versus Clozapine and Risperidone with refractory schizophrenia. The New England Journal of Medicine, 354, 472–482.
17. E.V.Harel, & Y.Levkovitz, (2008) Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression:A review. The Israel Journal of Psychiatry and Related Sciences, 45, 121–128.
18. H.Akiskal, ; E.Hantouche, ; & J.Allilaire, (2003) Validating antidepressant-associated hypomania (bipolar III):A systematic comparison with spontaneous hypomania (bipolar II). Journal of Affective Disorders, 73, 65–74.
19. J.Goldberg, & C.Truman, (2003) Antidepressant-induced mania:An overview of current controversies. Bipolar Disorders, 5, 407–420.
20. World Health Organization. (2013). Draft comprehensive mental health action plan 2013–2020. Geneva, Switzerland:World Health Organization.
21. H.Jack, ; M.Canavan, ; A.Ofori-Atta, ; L.Taylor, ; & E.Bradley, (2013) Recruitment and retention of mental health workers in Ghana. PLoSONE, 8.
22. A.L.Ofori-Atta, ; T.Mirzoev, ; A.Mensah-Kufuor, ; A.Osei, ; A.Dzadey, ; (2013). Experience of strengthening the mental health information system in Ghana’s three psychiatric hospitals. In Changing trends in mental health care and research in Ghana:Reader in psychiatry. A.Ofori-Atta, & S.Ohene, (eds.). University of Ghana 60th Anniversary Series.
23. M.E.Hulscher, ; R.P.Grol, ; & J.W.Van der Meer, (2010) Antibiotic prescribing in hospitals:A social and behavioural scientific approach. The Lancet Infectious Diseases, 10, 167–175.
24. J.Avorn, & D.Solomon, (2000) Cultural and economic factors that shape antibiotic use:The nonpharmacological basis of therapeutics. Annals of Internal Medicine, 133, 128–135.
25. B.D.Fulton, ; R.M.Scheffler, ; S.P.Sparkes, ; E.Y.Auh, ; M.Vujicic, ; (2011) Health workforce skill mix and task shifting in low income countries:A review of recent evidence. Human Resources for Health, 9, 1–11.
26. A.Dixon, ; D.McDaid, ; M.Knapp, ; & C.Curran, (2006) Financing mental health services in low- and middle-income countries. Health Policy and Planning, 21, 171–182.
27. M.Skelton, ; W.Khokhar, ; & S.Thacker, (2015) Treatment for delusional disorder. Cochrane Database Systmatic Reviews, 22.